Form 8-K - Current report:
SEC Accession No. 0001213900-24-076949
Filing Date
2024-09-09
Accepted
2024-09-09 16:29:15
Documents
16
Period of Report
2024-09-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0213868-8k_180life.htm   iXBRL 8-K 38043
2 SEPARATION AND RELEASE AGREEMENT DATED SEPTEMBER 5, 2024 AND FIRST AMENDMENT TO ea021386801ex10-1_180life.htm EX-10.1 91223
3 INDEMNITY AGREEMENT DATED SEPTEMBER 3, 2024 AND EFFECTIVE SEPTEMBER 5, 2024, BET ea021386801ex10-2_180life.htm EX-10.2 101825
  Complete submission text file 0001213900-24-076949.txt   503554

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE atnf-20240905.xsd EX-101.SCH 3787
5 XBRL DEFINITION FILE atnf-20240905_def.xml EX-101.DEF 26629
6 XBRL LABEL FILE atnf-20240905_lab.xml EX-101.LAB 36680
7 XBRL PRESENTATION FILE atnf-20240905_pre.xml EX-101.PRE 25253
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0213868-8k_180life_htm.xml XML 5818
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 241287579
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)